Metagenomi Therapeutics (MGX) Retained Earnings (2023 - 2026)
Metagenomi Therapeutics (MGX) posted quarterly Retained Earnings of -$44000.0 for Q1 2026, down 107.09% year-over-year from $621000.0 in Q1 2025, and down 116.92% quarter-over-quarter from $260000.0 in Q4 2025.
Metagenomi Therapeutics (MGX) Retained Earnings (2023 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has reported Retained Earnings for 4 consecutive years, with -$44000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 107.09% year-over-year to -$44000.0; the TTM figure through Mar 2026 stood at -$44000.0 (down 107.09% YoY), while the FY2025 annual figure was $260000.0, down 63.33% from the prior year.
- Retained Earnings declined to -$44000.0 in Q1 2026 per MGX's latest filing, from $260000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $709000.0 in Q4 2024 and bottomed at -$288.3 million in Q3 2025.
- Historically, Retained Earnings has averaged -$93.5 million across 4 years, with a median of -$187500.0 in 2023.
- Annual changes were most pronounced in 2024 — Retained Earnings soared 830.93% — and 2026, when it plunged 107.09%.
- Metagenomi Therapeutics' Retained Earnings stood at -$97000.0 in 2023, then jumped by 830.93% to $709000.0 in 2024, then tumbled by 63.33% to $260000.0 in 2025, then tumbled by 116.92% to -$44000.0 in 2026.
- Business Quant data shows MGX's Retained Earnings at -$44000.0 in Q1 2026, $260000.0 in Q4 2025, and -$288.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Metagenomi Therapeutics | 46.51 Mn | 46.51 Mn | - | 474.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 474.10 Mn |
| Mar 31, 2026 | -44,000.00 |
| Dec 31, 2025 | 260,000.00 |
| Sep 30, 2025 | -288.34 Mn |
| Jun 30, 2025 | -267.90 Mn |
| Mar 31, 2025 | 621,000.00 |
| Dec 31, 2024 | 709,000.00 |
| Sep 30, 2024 | -199.60 Mn |
| Jun 30, 2024 | -180.80 Mn |
| Mar 31, 2024 | -278,000.00 |
| Dec 31, 2023 | -97,000.00 |